Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
48.23
+0.36 (0.75%)
Oct 9, 2026, 4:00 PM EDT - Market closed
PBH Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,285 | 2,805 | 4,259 | 3,603 | 3,112 | 2,658 | |
Market Cap Growth | -26.64% | -34.15% | 18.21% | 15.77% | 17.10% | 20.91% |
Enterprise Value | 4,263 | 3,821 | 5,235 | 4,752 | 4,473 | 4,198 |
Last Close Price | 48.23 | 59.27 | 85.97 | 72.56 | 62.63 | 52.94 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.49 | 14.74 | 19.85 | 17.21 | - | 12.94 |
Forward PE | 10.25 | 12.58 | 17.90 | 15.89 | 14.53 | 12.82 |
PS Ratio | 2.07 | 2.58 | 3.74 | 3.20 | 2.76 | 2.44 |
PB Ratio | 1.19 | 1.49 | 2.32 | 2.18 | 2.15 | 1.69 |
P/FCF Ratio | 9.71 | 11.38 | 17.51 | 15.05 | 14.02 | 10.62 |
P/OCF Ratio | 9.16 | 10.89 | 16.93 | 14.47 | 13.55 | 10.22 |
PEG Ratio | 1.28 | 1.80 | 2.33 | 1.87 | 1.71 | 1.51 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.86 | 3.51 | 4.60 | 4.22 | 3.97 | 3.86 |
EV/EBITDA Ratio | 13.10 | 11.22 | 13.80 | 12.74 | 11.76 | 11.40 |
EV/EBIT Ratio | 14.55 | 12.35 | 14.99 | 13.88 | 12.86 | 12.49 |
EV/FCF Ratio | 18.11 | 15.51 | 21.52 | 19.85 | 20.16 | 16.77 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.08 | 0.55 | 0.57 | 0.69 | 0.95 | 0.96 |
Debt / EBITDA Ratio | 5.86 | 2.84 | 2.36 | 2.59 | 3.06 | 3.61 |
Debt / FCF Ratio | 8.78 | 4.24 | 4.29 | 4.76 | 6.16 | 6.02 |
Net Debt / Equity Ratio | 1.03 | 0.52 | 0.52 | 0.66 | 0.90 | 0.94 |
Net Debt / EBITDA Ratio | 6.08 | 2.88 | 2.49 | 2.93 | 3.44 | 4.02 |
Net Debt / FCF Ratio | 8.41 | 3.98 | 3.89 | 4.57 | 5.90 | 5.91 |
Asset Turnover | 0.28 | 0.32 | 0.34 | 0.34 | 0.32 | 0.31 |
Inventory Turnover | 2.91 | 3.15 | 3.45 | 3.28 | 3.50 | 3.90 |
Quick Ratio | 1.80 | 2.12 | 2.67 | 1.86 | 1.40 | 1.16 |
Current Ratio | 3.23 | 3.57 | 4.21 | 3.20 | 2.44 | 2.05 |
Return on Equity (ROE) | 9.12% | 10.22% | 12.30% | 13.50% | -5.44% | 13.99% |
Return on Assets (ROA) | 4.58% | 5.61% | 6.50% | 6.42% | 6.19% | 5.92% |
Return on Invested Capital (ROIC) | 6.36% | 8.09% | 9.54% | 9.44% | 11.97% | 8.91% |
Return on Capital Employed (ROCE) | 6.60% | 9.20% | 10.60% | 10.70% | 10.90% | 9.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.53% | 6.78% | 5.04% | 5.81% | -2.65% | 7.73% |
FCF Yield | 10.30% | 8.79% | 5.71% | 6.64% | 7.13% | 9.42% |
Buyback Yield / Dilution | 3.62% | 2.72% | 0.19% | -0.58% | 1.87% | -0.47% |